The 20 Best Acute Myeloid Leukemia (AML) Doctors Near Me

Tapan Kadia is a Hematologist practicing medicine in Cary, North Carolina. Dr. Kadia is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Martin Tallman is a Hematologist practicing medicine in New York, New York. Dr. Tallman is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Acute Myeloid Leukemia (AML), Hairy Cell Leukemia (HCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Bayard Powell is an Oncologist practicing medicine in Winston Salem, North Carolina. Dr. Powell is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Leukemia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Aspiration. Dr. Powell is currently accepting new patients.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Konopleva is currently accepting new patients.

Mark J. Levis, M.D., Ph.D., professor of oncology, medicine and pharmacology in the Division of Hematologic Malignancies at the Johns Hopkins University School of Medicine, co-directs the Hematologic Malignancies and Bone Marrow Transplantation Program and directs the Adult Leukemia Service at the Johns Hopkins Sidney Kimmel Cancer Center. In addition to his role within the Kimmel Cancer Center, he serves on the faculty for the Johns Hopkins Graduate Training Program in Cellular and Molecular Medicine, a Ph.D. program that prepares scientists to conduct laboratory research at the cellular and molecular level that is designed to have a direct impact on the understanding of human diseases. Dr. Levis has expertise in acute and chronic myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes. Dr. Levis received his medical degree at the University of California, San Francisco School of Medicine, where he also earned his Ph.D. in Biochemistry. He completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology. Dr. Levis is a member of the American Society of Hematology, the American Society of Clinical Oncology and the European Hematology Association. He is an ad hoc member of the Oncology Drug Advisory Committee, as well as an ad hoc manuscript referee for peer-reviewed journals such as New England Journal of Medicine; Leukemia; Clinical Cancer Research; and The American Journal of Hematology. Dr. Levis has earned numerous awards, such as the Daniel Nathans Research Award from Johns Hopkins University, the Osler Housestaff Teaching Award, the Director's Teaching Award in Clinical Science, and the Advanced Clinical Research Award from the American Society of Clinical Oncology. Dr. Levis’ laboratory research focuses on the development of molecularly-targeted therapies for leukemia. He is actively involved in the pre-clinical and clinical development of small molecule inhibitors of protein kinases, including FLT3. The research involves studying the biochemical effects of these inhibitors on samples taken from leukemia patients, with the broad goal of identifying and validating novel molecular therapeutic targets in these hematopoietic malignancies. While Dr. Levis plays a key role in the pre-clinical development of these therapies, he is particularly interested in translating this research to the bedside of his patients by using correlative studies to incorporate these novel therapies into existing treatments. In addition to his work in both the clinic and the laboratory, Dr. Levis has also conducted talks, mentorship and teaching lectures, and published extensively in the top journals in his field, including Leukemia; Blood; and the New England Journal of Medicine. Dr. Levis is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Levis is currently accepting new patients.

Amit K. Verma, MD, is Chair, Department of Oncology, Associate Director of Translational Science, Montefiore Einstein Comprehensive Cancer Center, Professor, Medical Oncology and Professor, Developmental & Molecular Biology, Albert Einstein College of Medicine. Dr. Verma is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Verma is currently accepting new patients.

Elizabeth Cull is an Oncologist and a Hematologist Oncology provider practicing medicine in Greenville, South Carolina. Dr. Cull is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Cull is board certified in American Board Of Internal Medicine. Dr. Cull is currently accepting new patients.

Jessica Altman is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Altman is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Altman is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Altman is currently accepting new patients.

Yu Chen is a primary care provider, practicing in Internal Medicine in Dallas, Texas. Dr. Chen is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 215 other conditions, according to our data. Her clinical expertise encompasses Liver Failure, Acute Tubular Necrosis, Cerebral Hypoxia, Endovascular Embolization, and Bone Marrow Aspiration. Dr. Chen is currently accepting new patients.

Todd Rosenblat is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Rosenblat is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic B-Cell Leukemia (CBCL), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Rosenblat is currently accepting new patients.

Hagop Kantarjian is an Oncologist practicing medicine in Houston, Texas. Dr. Kantarjian is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Splenectomy.

Franco Locatelli practices practicing medicine in Rome, Italy. Mr. Locatelli is rated as an Elite expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 67 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Splenectomy.

William Wierda is a Hematologist and an Oncologist practicing medicine in Houston, Texas. Dr. Wierda is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Naval Daver is an Oncologist practicing medicine in Houston, Texas. Dr. Daver is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Gastrostomy.

Daniel Deangelo is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Deangelo is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Lymphoblastic Leukemia (ALL), Mast Cell Activation Syndrome (MCAS), and Bone Marrow Aspiration. Dr. Deangelo is currently accepting new patients.

Robin Foa practices practicing medicine in Rome, Italy. Foa is rated as an Elite expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). They are also highly rated in 32 other conditions, according to our data. Their clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Tissue Biopsy.

Gail Roboz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Roboz is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Roboz is currently accepting new patients.

Jing Liu is a primary care provider, practicing in Family Medicine in North Little Rock, Arkansas. Dr. Liu is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 302 other conditions, according to our data. Her clinical expertise encompasses Cerebral Hypoxia, Hypertension, Leukemia, Endoscopy, and Ureteral Reconstruction.

Alok Srivastava is a primary care provider, practicing in Internal Medicine in Waterford, Wisconsin. Dr. Srivastava is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Hemophilia A, Blood Clots, Beta Thalassemia, Kidney Transplant, and Nephrectomy. Dr. Srivastava is board certified in American Board Of Internal Medicine. Dr. Srivastava is currently accepting new patients.

Lan-ping Xu practices practicing medicine in Beijing, China. Xu is rated as an Elite expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). They are also highly rated in 26 other conditions, according to our data. Their clinical expertise encompasses Graft Versus Host Disease (GvHD), Thrombocytopenia, Aplastic Anemia, Bone Marrow Transplant, and Bone Graft.